Hygenica

Hygenica MedTech develops antimicrobial medical devices that protect patients from nosocomial infections, translating scientific innovation from bench to bedside to address the urgent public health challenge of antimicrobial resistance (AMR). In collaboration with leading clinicians and scientists specialising in infection control, antibiotic stewardship, and pandemic preparedness, Hygenica supports the clinical adoption of its Fantex® technology, which demonstrates best-in-class efficacy against drug-resistant and multi-drug-resistant pathogens. The company is committed to reducing the burden of healthcare-associated infections (HCAIs) in global medical practice and has been recognised with the prestigious Queen’s Award to Industry for its outstanding achievements in technological innovation.